Stock listing
OTC:ACUT Accustem Sciences Inc Stock
Follow Accustem Sciences Inc into a list and get an email when it puts out news.
Share price · OTC:ACUT
$0.118 USD 0.000 (0.0%)
Close on Nov 18, 2026
- Day range
- $0.118 – $0.118 USDNov 18, 2026
- Volume
- 100 sharesNov 18, 2026
- Market cap
- $1.90M USDAt the close on Nov 18, 2026 · price × 16.07M shares outstanding
- 52-week range
- $0.117 – $0.998 USDLowest and highest trades, Nov 19, 2025 – Nov 18, 2026
- Traded on an average day
- $452 USDMedian day 49 shares · 26 days with no trades · last 3 months, Aug 18, 2026 – Nov 18, 2026

Daily closes
Last 3 months, Aug 18, 2026 – Nov 18, 2026 · OTC:ACUT · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.118 | 0.000 | 0.0% | $0.118 | $0.118 | $0.118 | 100 | |
| $0.118 | -0.012 | -9.2% | $0.126 | $0.126 | $0.118 | 610 | |
| $0.130 | -0.007 | -5.0% | $0.130 | $0.130 | $0.130 | 1,581 | |
| $0.137 | +0.007 | +5.3% | $0.137 | $0.137 | $0.137 | 125 | |
| $0.130 | 0.000 | 0.0% | $0.130 | $0.130 | $0.130 | 309 | |
| $0.130 | -0.013 | -9.0% | $0.130 | $0.130 | $0.130 | 250 | |
| $0.143 | -0.007 | -4.7% | $0.143 | $0.143 | $0.143 | 630 | |
| $0.150 | +0.020 | +15.4% | $0.150 | $0.150 | $0.150 | 4 | |
| $0.130 | -0.020 | -13.3% | $0.130 | $0.130 | $0.130 | 300 | |
| $0.150 | 0.000 | 0.0% | $0.150 | $0.150 | $0.150 | 0 | |
| $0.150 | -0.005 | -3.2% | $0.136 | $0.150 | $0.136 | 5,110 | |
| $0.155 | +0.021 | +15.9% | $0.155 | $0.160 | $0.155 | 16,997 | |
| $0.134 | -0.014 | -9.4% | $0.134 | $0.134 | $0.134 | 356 | |
| $0.148 | 0.000 | 0.0% | $0.148 | $0.148 | $0.148 | 0 | |
| $0.148 | 0.000 | 0.0% | $0.148 | $0.148 | $0.148 | 0 | |
| $0.148 | 0.000 | 0.0% | $0.148 | $0.148 | $0.148 | 0 | |
| $0.148 | 0.000 | 0.0% | $0.148 | $0.148 | $0.148 | 0 | |
| $0.148 | 0.000 | 0.0% | $0.148 | $0.148 | $0.148 | 0 | |
| $0.148 | 0.000 | 0.0% | $0.148 | $0.148 | $0.148 | 0 | |
| $0.148 | -0.003 | -1.7% | $0.160 | $0.160 | $0.148 | 12,826 | |
| $0.150 | +0.010 | +7.1% | $0.150 | $0.150 | $0.150 | 1,584 | |
| $0.140 | +0.005 | +3.7% | $0.150 | $0.150 | $0.140 | 257 | |
| $0.135 | 0.000 | 0.0% | $0.135 | $0.135 | $0.135 | 1,069 | |
| $0.135 | 0.000 | 0.0% | $0.135 | $0.135 | $0.135 | 0 | |
| $0.135 | 0.000 | 0.0% | $0.135 | $0.135 | $0.135 | 0 | |
| $0.135 | 0.000 | 0.0% | $0.135 | $0.135 | $0.135 | 0 | |
| $0.135 | +0.015 | +12.5% | $0.135 | $0.135 | $0.135 | 1,193 | |
| $0.120 | 0.000 | 0.0% | $0.120 | $0.120 | $0.120 | 0 | |
| $0.120 | 0.000 | 0.0% | $0.120 | $0.120 | $0.120 | 0 | |
| $0.120 | 0.000 | 0.0% | $0.120 | $0.120 | $0.120 | 0 | |
| $0.120 | 0.000 | 0.0% | $0.120 | $0.120 | $0.120 | 0 | |
| $0.120 | +0.003 | +2.6% | $0.120 | $0.120 | $0.120 | 401 | |
| $0.117 | -0.013 | -10.1% | $0.139 | $0.139 | $0.117 | 482 | |
| $0.130 | 0.000 | 0.0% | $0.130 | $0.130 | $0.130 | 0 | |
| $0.130 | 0.000 | 0.0% | $0.130 | $0.130 | $0.130 | 0 | |
| $0.130 | 0.000 | 0.0% | $0.130 | $0.130 | $0.130 | 49 | |
| $0.130 | -0.006 | -4.3% | $0.130 | $0.130 | $0.130 | 15,062 | |
| $0.136 | -0.016 | -10.5% | $0.161 | $0.161 | $0.136 | 20,112 | |
| $0.152 | -0.013 | -8.0% | $0.170 | $0.170 | $0.152 | 14,894 | |
| $0.165 | -0.015 | -8.2% | $0.165 | $0.165 | $0.165 | 106 | |
| $0.180 | +0.020 | +12.5% | $0.181 | $0.181 | $0.173 | 8,972 | |
| $0.160 | 0.000 | 0.0% | $0.160 | $0.160 | $0.160 | 0 | |
| $0.160 | 0.000 | 0.0% | $0.160 | $0.185 | $0.160 | 110 | |
| $0.160 | 0.000 | 0.0% | $0.160 | $0.160 | $0.160 | 0 | |
| $0.160 | 0.000 | 0.0% | $0.160 | $0.160 | $0.160 | 300 | |
| $0.160 | 0.000 | 0.0% | $0.160 | $0.160 | $0.160 | 0 | |
| $0.160 | 0.000 | 0.0% | $0.160 | $0.160 | $0.160 | 0 | |
| $0.160 | 0.000 | 0.0% | $0.160 | $0.160 | $0.160 | 0 | |
| $0.160 | 0.000 | 0.0% | $0.160 | $0.160 | $0.160 | 0 | |
| $0.160 | 0.000 | 0.0% | $0.160 | $0.160 | $0.160 | 10 | |
| $0.160 | 0.000 | 0.0% | $0.160 | $0.160 | $0.160 | 0 | |
| $0.160 | 0.000 | 0.0% | $0.160 | $0.160 | $0.160 | 0 | |
| $0.160 | 0.000 | 0.0% | $0.160 | $0.160 | $0.160 | 0 | |
| $0.160 | -0.065 | -28.9% | $0.230 | $0.230 | $0.160 | 41,517 | |
| $0.225 | 0.000 | 0.0% | $0.225 | $0.225 | $0.225 | 0 | |
| $0.225 | -0.015 | -6.2% | $0.225 | $0.225 | $0.220 | 14,606 | |
| $0.240 | +0.001 | +0.4% | $0.222 | $0.240 | $0.222 | 2,615 |
- Ticker
- OTC:ACUT
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- OTC
- Currency
- USD
What changed lately
Latest deck · Sep 30, 2026
Investor Presentation (September 2026)
Investor deck · 15 slides
Accustem Sciences Inc on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- Decks
- 7 decks · latest Sep 30, 2026
Valuation
Statements: 4 quarters to Sep 30, 2026 · price Nov 18, 2026
- Enterprise value
- $1.88M USD
- P/E
- Loss
- EV/sales
- No revenue
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- Negative equity
- Gross margin
- No revenue
- Operating margin
- No revenue
- Net margin
- No revenue
- Debt to equity
- Negative equity
- Beta vs S&P 500
- 0.19
Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Accustem Sciences Inc · OTC:ACUT | US$1.90M | US$1.88M | n/a | n/a | n/a | n/a | n/a | n/a | 0.19 |
| Telo Genomics Corp. · TSXV:TELO | US$2.80M | US$2.12M | n/a | n/a | n/a | n/a | n/a | n/a | 0.04 |
| Advanced Biomed Inc. · NASDAQ:ADVB | US$2.73M | US$3.12M | 0.5× | 12.2× | n/a | 0.2× | n/a | 0.1× | 0.35 |
| Innovotech Inc. · TSXV:IOT | US$2.66M | US$2.51M | n/a | 1.0× | n/a | 1.5× | −21.1% | 0.1× | 0.39 |
| Qlife Holding AB · OMXSTO:QLIFE | US$2.49M | US$2.88M | n/a | 34.1× | n/a | 9.6× | n/a | 3.1× | n/a |
| Physiomics PLC · LSE:PYC | US$2.46M | US$1.91M | n/a | 1.6× | n/a | 3.6× | −74.1% | 0.0× | n/a |
| 20/20 BioLabs, Inc. · NASDAQ:AIDX | US$2.10M | −US$1.01M | n/a | −0.5× | n/a | 3.4× | −317.8% | 0.9× | 1.41 |
| Bluejay Diagnostics, Inc. · NASDAQ:BJDX | US$1.90M | −US$5.43M | n/a | n/a | n/a | 0.3× | n/a | 0.0× | 1.71 |
| InVitro International · OTC:IVRO | US$1.87M | US$644,260 | 29.6× | 0.8× | 14.0× | 1.1× | 8.2% | 0.0× | 0.17 |
| Co-Diagnostics, Inc. · NASDAQ:CODX | US$1.36M | US$2.21M | n/a | 2.6× | n/a | 0.1× | n/a | 0.2× | 2.16 |
| Prostatype Genomics AB · OMXSTO:PROGEN | US$1.36M | US$1.32M | n/a | 13.3× | n/a | 2.1× | n/a | 0.0× | n/a |
| Median of the others | US$2.28M | US$2.02M | 15.1× | 2.1× | 14.0× | 1.5× | −47.6% | 0.1× | 0.39 |
Team and board
Officers
| Officer | Role |
|---|---|
| Wendy Blosser | Chief Executive Officer |
| Jeff Fensterer | Chief Operations Officer |
| Joe Flanagan | Chief Business Officer |
| Keeren Shah | Chief Finance Officer |
Board
| Director | Role |
|---|---|
| Gabriele Cerrone | Board Member |
| John Brancaccio | Board Member |
| Sean McDonald | Board Member |
| Willy Simon | Board Member |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q2 2024 | Sep 16, 2024 · Before open | +30.1% |
| Q1 2024 | May 20, 2024 · Before open | +13.8% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (September 2026) | Investor deck | 15 slides | Sep 30, 2026 |
| Investor Presentation (February 2026) | Investor deck | 16 slides | Feb 18, 2026 |
| Investor Presentation (September 2025) | Investor deck | 18 slides | Sep 18, 2025 |
| Investor Presentation (October 2023) | Investor deck | 16 slides | October 2023 |
| Investor Presentation (June 2023) | Investor deck | 17 slides | Jun 8, 2023 |
| Investor Presentation (May 2023) | Investor deck | 21 slides | May 23, 2023 |
| Investor Presentation (December 2022) | Investor deck | 19 slides | Dec 1, 2022 |
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development | 281.0K | 138.3K | 139.7K | 266.9K | 73.3K |
| Operating income | -1.76M | -1.51M | -2.05M | -3.75M | -670.6K |
| Depreciation and amortization | 418 | 3.63K | 3.63K | 3.32K | |
| EBITDA | -1.76M | -1.50M | -2.05M | -3.74M | |
| Income before tax | -1.76M | -1.51M | -2.05M | -3.75M | -670.6K |
| Net income | -1.76M | -1.51M | -2.05M | -3.75M | -670.6K |
| Earnings per share, basic | -0.12 | -0.13 | -0.18 | -0.34 | -0.07 |
| Earnings per share, diluted | -0.12 | -0.13 | -0.18 | -0.34 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash and equivalents | 13.9K | 5.05K | 21.5K | 734.0K | |
| Current assets | 49.4K | 50.4K | 129.8K | 932.0K | 1.35M |
| Property, plant and equipment | 418 | 4.05K | 7.68K | ||
| Total assets | 1.55M | 50.9K | 133.9K | 939.7K | 1.35M |
| Accounts payable | 703.8K | 804.6K | 578.4K | 311.8K | 388.7K |
| Current liabilities | 4.95M | 3.36M | 2.25M | 1.08M | 702.7K |
| Total liabilities | 4.95M | 3.36M | 2.25M | 1.08M | 702.7K |
| Shareholders' equity | -3.40M | -3.31M | -2.11M | -139.6K | 650.7K |
| Shares outstanding | 16.1M | 12.1M | 11.3M | 11.3M | 10.00M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Cash from operations | -850.4K | -664.1K | -1.62M | -1.81M |
| Capital spending | -11.0K | |||
| Free cash flow | -1.82M | |||
| Cash from investing | -11.0K | |||
| Cash from financing | 859.3K | 647.6K | 903.1K | 2.55M |
| Change in cash | 8.88K | -16.4K | -712.5K | 734.0K |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 10-Q · Quarterly report | Nov 20, 2026 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | Nov 16, 2026 | Explanation request | SEC |
| 10-Q · Quarterly report | Aug 14, 2026 | Quarterly report | SEC |
| 10-Q · Quarterly report | May 15, 2026 | Quarterly report | SEC |
| 10-K · Annual report | Apr 14, 2026 | Annual report | SEC |
| NT 10-K · Late filing notice | Mar 31, 2026 | Explanation request | SEC |
| 8-K · Current report | Nov 26, 2025 | Current report | SEC |
| 10-Q · Quarterly report | Nov 12, 2025 | Quarterly report | SEC |
| 10-Q · Quarterly report | Aug 14, 2025 | Quarterly report | SEC |
| 4 · Change in ownership | Jun 16, 2025 | Insider trade | SEC |
All 78 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Jun 13, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | May 20, 2025 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | May 15, 2025 | Explanation request | SEC |
| 4 · Change in ownership | Apr 10, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 8, 2025 | Insider trade | SEC |
| 10-K · Annual report | Apr 3, 2025 | Annual report | SEC |
| NT 10-K · Late filing notice | Mar 31, 2025 | Explanation request | SEC |
| SEC STAFF ACTION | Feb 21, 2025 | Other filings | SEC |
| 4 · Change in ownership | Jan 3, 2025 | Insider trade | SEC |
| 8-K/A · Current report, amended | Jan 2, 2025 | Current report | SEC |
| 8-K · Current report | Dec 30, 2024 | Current report | SEC |
| 10-Q · Quarterly report | Nov 18, 2024 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | Nov 14, 2024 | Explanation request | SEC |
| 10-Q · Quarterly report | Sep 16, 2024 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | Aug 14, 2024 | Explanation request | SEC |
| 10-Q · Quarterly report | May 20, 2024 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | May 15, 2024 | Explanation request | SEC |
| 8-K · Current report | Apr 10, 2024 | Current report | SEC |
| 10-K · Annual report | Mar 22, 2024 | Annual report | SEC |
| 10-Q · Quarterly report | Nov 13, 2023 | Quarterly report | SEC |
| 10-Q · Quarterly report | Aug 14, 2023 | Quarterly report | SEC |
| 8-K · Current report | Jun 9, 2023 | Management or board change | SEC |
| 8-K · Current report | Jun 6, 2023 | Current report | SEC |
| 10-Q · Quarterly report | May 5, 2023 | Quarterly report | SEC |
| 10-K/A · Annual report, amended | Apr 28, 2023 | Annual report | SEC |
| 10-K · Annual report | Feb 15, 2023 | Annual report | SEC |
| S-1/A · Registration statement, amended | Jan 19, 2023 | Offer document | SEC |
| 4 · Change in ownership | Jan 3, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Dec 5, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Nov 22, 2022 | Insider trade | SEC |
| S-1 · Registration statement | Nov 17, 2022 | Offer document | SEC |
| 8-K · Current report | Nov 16, 2022 | Management or board change | SEC |
| 10-Q · Quarterly report | Nov 8, 2022 | Quarterly report | SEC |
| 8-K · Current report | Oct 14, 2022 | Meeting outcome | SEC |
| DEFA14A · Additional proxy material | Oct 11, 2022 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Sep 14, 2022 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Sep 2, 2022 | Meeting notice | SEC |
| 10-Q · Quarterly report | Aug 12, 2022 | Quarterly report | SEC |
| 4 · Change in ownership | Aug 2, 2022 | Insider trade | SEC |
| DRS · Draft registration statement | Jul 29, 2022 | Offer document | SEC |
| 8-K · Current report | Jun 21, 2022 | Management or board change | SEC |
| 4 · Change in ownership | Jun 9, 2022 | Insider trade | SEC |
| 3 · Initial statement of ownership | May 27, 2022 | Insider trade | SEC |
| 3 · Initial statement of ownership | May 27, 2022 | Insider trade | SEC |
| 3 · Initial statement of ownership | May 27, 2022 | Insider trade | SEC |
| 10-Q · Quarterly report | May 20, 2022 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | May 16, 2022 | Explanation request | SEC |
| 4 · Change in ownership | Apr 27, 2022 | Insider trade | SEC |
| 10-K · Annual report | Apr 18, 2022 | Annual report | SEC |
| 8-K · Current report | Apr 5, 2022 | Material contract | SEC |
| NT 10-K · Late filing notice | Mar 31, 2022 | Explanation request | SEC |
| 8-K · Current report | Mar 10, 2022 | Management or board change | SEC |
| 3 · Initial statement of ownership | Jan 14, 2022 | Insider trade | SEC |
| 3 · Initial statement of ownership | Dec 9, 2021 | Insider trade | SEC |
| 3 · Initial statement of ownership | Dec 3, 2021 | Insider trade | SEC |
| 8-K · Current report | Dec 3, 2021 | Acquisition or disposal | SEC |
| EFFECT · Notice that a registration is effective | Jul 2, 2021 | Other filings | SEC |
| SEC STAFF ACTION | Jul 1, 2021 | Other filings | SEC |
| F-6 | Jun 23, 2021 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Jun 7, 2021 | Other filings | SEC |
| CORRESP · Letter to the SEC | May 28, 2021 | Other filings | SEC |
| 20FR12G/A | May 28, 2021 | Other filings | SEC |
| UPLOAD · Letter from the SEC | May 14, 2021 | Other filings | SEC |
| CORRESP · Letter to the SEC | May 6, 2021 | Other filings | SEC |
| 20FR12G/A | May 6, 2021 | Other filings | SEC |
| UPLOAD · Letter from the SEC | May 3, 2021 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Apr 8, 2021 | Other filings | SEC |
| 20FR12G | Mar 12, 2021 | Other filings | SEC |
Cap table
Built by 6ix from Accustem Sciences Inc’s releases · as of Nov 20, 2026
- Common shares
- 16,072,267
- Fully diluted
- 16,072,267
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 16,072,267 | Nov 20, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Nov 20, 2026 | 16,072,267 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Gabriele Cerrone | Board Member · Since at least Nov 5, 2026 |
| Jeff Fensterer | Chief Operations Officer · Since at least Nov 4, 2026 |
| Joe Flanagan | Chief Business Officer · Since at least Nov 4, 2026 |
| John Brancaccio | Board Member · Since at least Nov 5, 2026 |
| Keeren Shah | Chief Finance Officer · Since at least Nov 5, 2026 |
| Sean McDonald | Board Member · Since at least Nov 5, 2026 |
| Wendy Blosser | Chief Executive Officer · Since at least Nov 5, 2026 |
| Willy Simon | Board Member · Since at least Nov 4, 2026 |
Log in to ask 6ix AI your own questions about Accustem Sciences Inc.